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INTRODUCTION 
Hinchey and co workers in 1996 first described a clinico-radiologic 
entity, in which patients presented with a symptom complex of sudden 
onset headache, altered sensorium, visual symptoms and seizures that, 
was later termed as Posterior Reversible Encephalopathy Syndrome 
(PRES). 
Posterior Reversible Encephalopathy syndrome is a syndrome in 
which abrupt rise in blood pressure or use of certain drugs or sepsis leads 
to sudden onset of headache, altered sensorium, visual symptoms and 
seizures. 
These symptoms occur in various combinations or sometimes in 
isolation. Hence a high index of suspicion to diagnose this syndrome is 
essential whenever a clinical setting that can predispose to Posterior 
Reversible Encephalopathy Syndrome exists. 
Cases of Posterior Reversible Encephalopathy Syndrome are 
reported from age 4 up to 90 years of age, however most cases occur in 
the young and the middle age group (14). 
There  is  a  high  female  preponderance  for  Posterior  Reversible 
Encephalopathy   Syndrome  as  the  cause  of   the   disease  is  often  
pre-eclampsia or eclampsia. Other common co morbidities are renal 
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failure, systemic hypertension presenting as accelerated hypertension, 
bone marrow transplantation and solid organ transplantation (1,14) 
Clinical symptoms resolve within few days to weeks with 
appropriate treatment. Though the term Posterior Reversible 
Encephalopathy Syndrome denotes reversible encephalopathy, 
irreversible neurologic deficit occurs if prompt identification of the 
disease and early appropriate intervention is not done.  
Ischemic infarcts and hemorrhages are the complications of 
posterior reversible encephalopathy syndrome that lead to persistent 
neurological deficit. 
PRES: Pathophysiology 
 The Pathophysiology of Posterior Reversible Encephalopathy 
Syndrome is still elusive. Two theories have been postulated – the 
hyperperfusion theory and the hypoperfusion theory. 
PRES: Pathophysiology in patient with hypertension 
Systemic Hypertension is a common medical problem worldwide. 
It is the commonest cause of Posterior Reversible Encephalopathy 
Syndrome.  
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The hyperperfusion theory is implicated here. The rapidity of   rise 
of blood pressure is more important than the absolute value of blood 
pressure in the development of Posterior Reversible Encephalopathy 
Syndrome.  
The exact pathophysiology of Posterior Reversible Encephalopathy 
Syndrome is still undetermined. It is postulated the raise in blood pressure 
causes vasodilatation, hyperperfusion, blood-brain-barrier breach and 
extravasation of intravascular fluid into the interstitium leading to 
vasogenic cerebral edema and Posterior Reversible Encephalopathy 
Syndrome. 
There is a protective, compensatory mechanism for this excessive 
vasodilatation, namely the cerebral autoregulation mediated by the 
sympathetic nerves. This autoregulation maintains constant blood flow to 
the brain in spite of blood pressure fluctuations.  
These sympathetic nerves mediate vasoconstriction and is effective 
in preventing excessive vasodilatation and cerebral edema formation. 
There is a rich sympathetic innervation of the internal carotid and anterior 
cerebral circulation where as the posterior circulation, the basilar artery 
and its branches have only sparse sympathetic innervation.  
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Hence when there is an abrupt raise in the blood pressure in the 
less protected posterior circulation there is vasodilatation, extravasation 
of fluid into the interstitium causing vasogenic edema and Posterior 
Reversible Encephalopathy Syndrome.  
When the mean arterial pressure (MAP) is within the range of 60 -
120 mmHg the cerebral auto regulation is intact, causing variable 
vasodilatation and vasoconstriction, thereby maintaining the cerebral 
blood flow at around 40 - 60 ml / min / 100 grams of brain tissue.  
However when the mean arterial pressure exceeds the value of 170 
mmHg the cerebral auto regulation is disrupted leading to vasogenic 
edema and Posterior Reversible Encephalopathy Syndrome. 
During many instances, however, a smaller MAP increase of even 
a few mmHg as seen often in pregnancy induced hypertension can cause 
disruption of cerebral autoregulation.  
PRES: Pathophysiology in patient without hypertension 
The First description of this disease entity – Posterior Reversible 
Encephalopathy Syndrome in 1996 was in a patient being treated with 
cyclosporine.  
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The drugs implicated in causing PRES are mainly the 
immunosuppressant drugs- like cyclosporine, cisplatin, oxaliplatin, 
Tacrolimus. Several other drugs like α- interferons and erythropoietin, 
cytarabine, methotrexate, rituximab, linezolide, high dose corticosteroid 
therapy etc. are also implicated in causing Posterior Reversible 
Encephalopathy Syndrome. (14) 
The mechanisms by which these drugs cause Posterior Reversible 
Encephalopathy Syndrome is multi factorial. They either cause drug 
induced hypertension and or endothelial damage.  
PRES: Pathophysiology in patients with Sepsis 
 Sepsis causes Posterior Reversible Encephalopathy Syndrome by 
two mechanisms – endothelial dysfunction and microcirculation 
abnormality. Endothelial dysfunction can be due to direct effect of the 
pathogen or secondary to mediators of inflammation.  
Microcirculation abnormality is due to the blockade of 
microvasculature by the leukocytes and inflammatory products. They 
block the microcirculation causing tissue hypo perfusion and also there is 
change in the vascular tone brought forth by the vasoactive substance 
released during inflammation.  
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This microcirculation changes in sepsis predispose to Posterior 
Reversible Encephalopathy Syndrome. Also infections like retro-viral 
infection (HIV) per se can precipitate Posterior Reversible 
Encephalopathy Syndrome, even when sepsis or septic shock has not 
occurred. 
 In patients of Posterior Reversible Encephalopathy Syndrome 
without hypertension i.e. PRES associated with infection, sepsis, certain 
drugs, endothelial surface antigens get up-regulated and there is release of 
endothelin which affects the vascular tone causing vasoconstriction and 
hypoperfusion. This hypoperfusion is followed by blood brain barrier 
dysfunction leading to vasogenic edema and Posterior Reversible 
Encephalopathy Syndrome. This is the cerebral hypoperfusion theory 
implicated in patients of Posterior Reversible Encephalopathy Syndrome 
without hypertension. 
Recurrent Posterior Reversible Encephalopathy Syndrome has 
been reported in 6% of patients. (14) 
Death following Posterior Reversible Encephalopathy Syndrome 
has been reported in up to 15% of the patients. (14) 
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This figure shows the two main hypotheses of posterior 
reversibnle encephalopathy syndrome (PRES) 
pathophysiology. One involves impaired cerebral 
autoregulation responsible for cerebral hyperfusion and blood 
brain barrier dysfunction. The other is related to cytotoxicity 
and involves endothelial dysfunction, blood brain barrier 
alteration and cerebral hypoperfusion. Under both hypotheses, 
the result of the cerebral blood perfusion abnormalities is 
cerebral vasogenic edema. 
 
14 
 
PRES and its complication – Pathophysiology  
 Cerebral infarction, hemorrhage and brain stem herniation are the 
irreversible complication of Posterior Reversible Encephalopathy 
Syndrome.  
 Cerebral infarction or cytotoxic injury occurs when the blood 
pressure is not controlled early and promptly – the endothelial 
dysfunction causes vasospasm leading to cerebral hypoperfusion, 
cytotoxic injury and infarction.  
Reperfusion causes bleeding into the infarcted area causing 
hemorrhagic infarct. These infarcts and hemorrhagic infarcts are 
associated with cytotoxic edema (Direct damage to cells) adding on to the 
vasogenic edema (mediated by the extravasated toxic blood products) that 
occurs early in this disease entity – raising the intracranial pressure 
further and cerebral herniation , death can occur, if not treated promptly.  
The Radiologic features of PRES     
 Vasogenic edema is the classical feature of Posterior Reversible 
Encephalopathy Syndrome. It commonly presents with bilateral 
symmetrical vasogenic edema typically involving the sub-cortical white 
matter, predominantly in the bilateral parietal occipital lobes – this is 
called the dominant parieto occipital pattern.  
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Sudden rise in the blood pressure exceed the auto regulatory 
capability of the vasculature of the brain causing regions of 
hyperperfusion (vasodilatation) and hypoperfusion (vasoconstriction) 
develops especially in the watershed zones and break down of the blood - 
brain barrier ensues with local extravasation of fluid and petechial 
hemorrhages.  
Diffusion – weighted images (DWI) typically show iso-intense or 
hypo-intense lesions, with hyper intensity in the corresponding areas in 
ADC due to increase in apparent diffusion coefficient for water, 
indicative of vasogenic brain edema.             
Other patterns are the holohemispheric water shed (anterior and 
posterior water shed) involving the frontal, parietal and occipital regions 
with less of temporal lobe involvement.  
The Superior frontal sulcus pattern – area of edema  that have 
patchy distribution along  the superior frontal sulci in the frontal lobe. 
The parieto – occipital lobes may or may not be involved.  
Partial expression of the three primary patterns with vasogenic 
edema involving both the parietal and frontal lobes but excluding the 
occipital lobe  may be seen. Asymmetric involvement may also be noted. 
This is the Partial and or Asymmetric pattern. 
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Clinical Manifestation of PRES 
 The classical presentation of Posterior Reversible Encephalopathy 
Syndrome is altered sensorium, headache, visual symptoms and seizures 
in various combinations or sometimes in isolation as well. Hence a high 
index of suspicion is required to diagnose this syndrome as mentioned 
earlier. 
Diagnosis of PRES 
PRES is a clinicoradiological diagnosis.  
Hence a clear knowledge, about the situations that could 
predispose to Posterior Reversible Encephalopathy Syndrome and the 
radiological patterns of PRES, is crucial to diagnose this condition. 
T2FLAIR, ADC, DWI sequences are important in diagnosing 
PRES. 
Treatment of PRES 
General Measures: 
Intensive care setting may be required in many cases. Most of the 
patients are hemodynamically stable but a few may require inotropic 
support. The patient may require endotracheal intubation and the need for 
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the same should be continuously assessed for upper airway protection in 
marked impairment of consciousness or resistant seizures. 
Rapid induction with thiopentone or propofol with succinylcholine 
(exclude hyperkalemia) are good choices, if endotracheal intubation is 
done. Hypoglycemia should be checked and corrected. 100mg of 
thiamine should be given, simultaneously to hypoglycemia correction 
especially if there is B1 vitamin deficiency possibility like hyperemesis 
gravidarum. 
Metabolic parameters should be closely monitored and particularly 
hypomagnesaemia should be promptly corrected. 
Control of Seizure: 
At the presentation of seizures, I.V lorazepam 0.1mg/ kg I.V. 
(maximum dose of 4mg) or diazepam 0.2 mg/ kg I.V. (maximum dose of 
10mg) over 1 minute. Allow 5 minutes to determine whether seizures 
terminate, if no response repeat once. 
If seizures persists, loading dose of phenytoin 20 mg/ kg I.V. at the 
maximum rate of 50 mg/ minute or phosphenytoin 15 – 18 mg phenytoin 
equivalent (PE)/ kg/ min I.V. at the maximum rate of 150mg PE/ min or 
phenobarbitone 20 mg/ kg I.V. at 60 mg/ min should be given. 
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Midazolam, propofol or thiopentone in titrated doses is needed in 
patients having refractory status epilepticus until the clinical seizure 
remits. 
For patients showing electrical status epilepticus, titrated doses of 
Midazolam, propofol or thiopentone is given until burst suppression is 
obtained, this is followed by continuous infusion of the drug for at least 
24 hours. 
Hypertensive emergency management 
Normalizing the blood pressure is not the aim here. Instead 
reducing the MAP by 20 – 25% within the first 2 hours and down the 
blood pressure to 160/100 mmHg within the first six hours is aimed at. 
More rapid or aggressive correction of blood pressure is not 
recommended because it can lead to cerebral hypoperfusion and cause 
infarct. 
I.V. antihypertensives are needed many times. I.V. labetalol, 
nicardipine are appropriate choices if available. I.V nitroprusside, 
nitroglycerine can be used. Anti-edema measures like mannitol, 
furosemide may be needed.  
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Underlying cause correction 
Etiological diagnosis of PRES should be identified early to allow 
prompt correction of the cause precipitating PRES. Blood pressure 
reduction, withdrawal of offending drug, termination of pregnancy – 
cesarean section, dialysis etc., may be required. Prompt treatment of the 
cause prevents irreversible complications and death. 
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AIM OF THE STUDY 
 
To study the etiological, clinical and radiological profile of patients 
diagnosed to have Posterior Reversible Encephalopathy Syndrome. 
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REVIEW OF LITERATURE 
Hinchey et al at New England Medical center, Boston, in 1996 first 
described a reversible disease entity in a series of 15 cases presenting 
with headache, altered sensorium, seizures, visual disturbance with 
findings of predominant posteriorly distributed leukoencephalopathy on 
brain imaging–he called this as reversible posterior leukoencephalopathy 
syndrome (RPLS) 
In 2000, Sean O Casey proposed the more appropriate term of 
Posterior Reversible Encephalopathy Syndrome - PRES instead of RPLS. 
This term Posterior Reversible Encephalopathy Syndrome is more apt as 
there is no leukoencephalopathy or destruction of the white matter as 
such but rather a vasogenic edema in the subcortical white matter 
following encephalopathy. 
Hinchey in N Eng J Med 1996 reported that “Of the 15 patients, 7 
were receiving immunosuppressive therapy after transplantation or as 
treatment for aplastic anemia, 1 was receiving interferon for melanoma, 3 
had eclampsia, and 4 had acute hypertensive encephalopathy associated 
with renal disease (2 with lupus nephritis, 1 with acute 
glomerulonephritis, and 1 with acetaminophen induced hepatorenal 
failure)”. He further documented that “12 patients had abrupt increases in 
blood pressure and 8 had some impairment of renal function”. The CT 
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and MRI imaging of these patients showed extensive subcortical white 
matter edema predominantly in the posterior cerebral hemisphere. These 
patients were “treated with antihypertensive medications, and 
immunosuppressive therapy was withdrawn or the dose reduced. In all 15 
patients, the neurological deficits resolved within 2 weeks”. 
The cause of PRES is multifactorial. The first description of 
Posterior Reversible Encephalopathy Syndrome was given in a patient 
receiving cyclosporine. By far the commonest causes are sudden 
elevation of blood pressure as seen in eclampsia, renal failure and usage 
of drugs like immunosuppressants. 
Sioane et al. noted blood brain barrier abnormality at autopsy, in 
two patients who were bone marrow transplant recipients treated with 
cyclosporine. Others have suggested that the toxic effect of cyclosporine 
is seen only in patients having pre- existing blood brain barrier breach. 
This hypothesis was commonly seen in liver transplant recipients 
receiving cyclosporine or Tacrolimus already had more episodes of 
encephalopathy prior to transplantation.  
Tdileman et al also confirmed that cyclosporine toxicity occurs 
only in patients with already pre existing blood brain barrier damage, 
secondary to infection. 
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Bartynski et al in 2007 reported 136 patients of Posterior 
Reversible Encephalopathy Syndrome with the clinical features: seizure 
activity in 97 (71%), consciousness impairment 39 (26%), headaches 39 
(26%), visual impairment 39 (26%), acute hypertension 97 (67%), focal 
neurological deficit not reported. The radiological features in cases of 
bartynski et al were bilateral lesions in 98 out of 136 patient studied 
(72%), asymmetric lesions in 21 out of 136 patients (16%), grey matter 
involvement was not reported, posterior > anterior in 30 patients (22%), 
occipital in 34 patients (99%), parietal in 134 patients (99%), frontal in 93 
patients (63%), temporal in 55 patients (40%). Some cases had brainstem, 
cerebellum and basal ganglion involvement. 
Casey et al in 2000 reported the radiological features of Posterior 
Reversible Encephalopathy Syndrome in 16 patients of which bilateral 
lesion was seen in 11 (16) patients, posterior > anterior in 15 (94%), 
parietal 8, occipital, not reported surprisingly, frontal 15(88%), temporal 
16(100%), brain stem and cerebellum – not reported, basal ganglia 
3(19%). 
McKinney et al in 2001 reported 76 cases of Posterior Reversible 
Encephalopathy Syndrome the most common clinical presentation he 
observed was seizure 76%, consciousness impairment 13% followed by 
headache and visual symptoms. The most common radiological feature in 
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his study was parietal – occipital (99%), followed by frontal (89%), 
temporal (68%). Few patients showed brainstem, cerebellum and basal 
ganglia involvement. 
Lee in 2008 reported “36 cases of Posterior Reversible 
Encephalopathy Syndrome of which 20 were females, 16 were males 
with a mean age of presentation being 44.7 years. Hypertension (53%), 
renal disease (45%), malignancy (32%), transplantation (24%), dialysis 
(21%), were the co-morbid conditions noted. Clinical presentation was 
seizures (92%), visual symptoms (39%), and headache (53%). The mean 
systolic blood pressure recorded was 187 mmHg at presentation.  
The clinical features resolved with treatment after about 5.3 days 
(mean average) the atypical features in MRI they reported were frontal 
lobe involvement in 22 (58%), grey matter 16 (42%), hemorrhage 2 (5%), 
unilateral lesion 2 (5%), infarct in 10 (26%), recurrent PRES 2 (5%), 
brainstem and cerebellum 22 (58%)”.  
Jennifer E fugate et al diagnosed 120 patients between 2005 to 
2009 prospectively. The mean peak systolic blood pressure was 199 mm 
Hg. The mean peak diastolic blood pressure was 109 mmHg. Etiologies 
were hypertension 69 out of 120 patients (61%), cytotoxic drugs 21 
(19%), preeclampsia or eclampsia 7(6%), sepsis 8 (7%), autoimmune 
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diseases 51 (45%), multiorgan dysfunction 1 (1%). The clinical features 
noted were seizure 84 (74%), altered sensorium 32 (28%), headache 29 
(26%), visual symptoms 23 (20%). Imaging showed that parieto occipital 
regions were commonly involved 108 (94%) followed by frontal lobe 
involvement 88 (77%), temporal lobe 74 (64%) and cerebellar 
involvement in 63 (53%). 
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MATERIALS AND METHODS 
Study Design  : Descriptive study  
Place of Study : Govt. Stanley Medical College  
and Hospital, Chennai-1. 
Study Period : January 2012 to January 2014. 
Study Population : All Patients with clinical suspicion of   
 Posterior Reversible Encephalopathy   
 Syndrome admitted/referred to the   
 Neurology Department, Government        
 Stanley Medical College and Hospital. 
Inclusion Criteria: 
Patients having clinical and radiological features consistent with 
Posterior Reversible Encephalopathy Syndrome  
Exclusion Criteria: 
Subcortical white matter lesions other than Posterior Reversible 
Encephalopathy Syndrome:   
Infection – Progressive Multifocal Leukoencephalopathy. 
Vascular – Posterior Circulation Stroke/ Superior Sagittal Sinus 
Thrombosis. 
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Neoplasms –Gliomatosis cerebri, Lymphoma, Glioma. 
Demyelination- Acute disseminated encephalomyelitis, Multiple 
Sclerosis. 
Dysmyelination- Leukodystrophies like Metachromatic 
leucodystrophy. 
Metabolic- severe hypoglycemia, hypotension. 
Methodology: 
A descriptive study done by analyzing the medical records of 
patients diagnosed to have Posterior Reversible Encephalopathy 
Syndrome over a period of two years. The clinical data, etiological and 
radiological features of these patients were collected for the study 
purpose. 
1) Consent to participate in the study was taken from the patients. 
2) A descriptive study analyzing the patients diagnosed to have PRES 
over a period of 2 years was done. 
3) Demographic data of the patients was obtained. 
4) The clinical features with which the patients presented were 
carefully noted. 
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5) The MRI brain was done for all patients and the radiological 
features noted were recorded. The images were interpreted by the 
radiologists at Government Stanley medical college and Hospital. 
6) The underlying cause or etiology of Posterior Reversible 
Encephalopathy Syndrome was identified and noted in each case. 
7) The treatment given and the clinical outcome after treatment were 
 noted. 
8) Persistent neurological deficit if any was recorded. 
 
Statistical Analysis 
 
Statistical analysis was performed using SPSS (Statistical Package 
for Social Sciences) 16.0 software. The  data collected as per the 
proforma was tabulated, using the above software analysis was done and 
results were obtained. 
  
1. There was a striking female preponderance in patients with 
Posterior Reversible Encephalopathy Syndrome, in this study, with 
27 (87.1 %) of females and 4 (12.9 %) of males. 
 
Fig 1: Gender Distribution of patients with PRES
 
2. The age of patients ranged from 15 years to 65 years. The mean 
age being 26.34 years. The common age group of Posterior 
Reversible Encephalopathy Syndrome in this study was 20 to 39 
years, 64% of the patients were in this age group.
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Fig 3: Age Distribution in PRES
affected are in the age group between 20 
 
3. The duration of symptoms before presentation to the hospital was a 
minimum of few hours to one day to a maximum
Fig 4: Diagram showing duration of the symptoms before 
presentation to the hospital
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4. The most common presenting complaint of Posterior Reversible 
Encephalopathy Syndrome in this study was headache. 87.09% of 
the patients had headache as 
 
Fig 5: Incidence of Headache in PRES
5. In this study, seizures were 
PRES. Seizures were 
The frequency of seizures ranged from one to
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Fig 6: Seizures in Patients with PRES
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6. Visual symptoms were
Fig 7: Visual 
 
7. Impaired consciousness was noted in 51.61% of the patients of 
Posterior Reversible Encephalopathy Syndrome in this study
 
Fig 8: Impaired consciousness in patients with PRES
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8. 15 out of the 31 patients in this study had visual complaints. The 
common visual complaints seen in the patients of PRES in this 
study were flashes of light, blurring of vision, flickers of light to 
field defects and cortical blindness. 
study presented with visual symptoms.
patients presented with visual symptoms. 
 
9. Many patients had various combination of all symptoms, 
sometimes in isolation as well, like headache alone, in 1 patient 
with pre eclampsia and impaired consciousness alone, in a patient 
of Posterior Reversible E
(End Stage Renal Disease) on hemodialysis.
Fig 9: Presenting symptoms of PRES 
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10. There was a varied aetiology of Posterior Reversible 
Encephalopathy Syndrome in this study. 18 out of the 31 cases i.e.  
58.06% of cases were pregnancy related 
 
Fig 10: Distribution of 
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Fig 11: Distribution of etiologies of PRES in this study
12. The duration of headache, at the time of first presentation to the 
hospital, ranged from 1 day to 14 days.
 
Fig 12: Duration of headache at the time of presentation to hospital.
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13. Amongst the pregnancy associated Posterior Reversible 
Encephalopathy Syndrome, pre
(19.35 %), antepartum eclampsia was seen in 8 cases ( 25.80%) 
and postpartum eclampsia in 4 cases (12.90% ), out of the total of 
31 patients. 
Fig 13: Pregnancy associated PRES
 
14. Hypertension was detected in 21 out of 31 patients. Amongst the
8 patients had pregnancy associated hypertension and 13 had non 
pregnancy associated hypertension.
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15. 11 of the 31 patients i.e. 32.25 % of patients had normal blood 
pressure. This supports the fact that the abrupt raise in blood 
pressure above  the baseline is more important than the absolute 
value of blood pressure in causing Posterior Reversible 
Encephalopathy Syndrome 
 
16. Amongst the 13 non pregnancy associated hypertension 2 had 
transient hypertension- 1 following PIGN, 1 following 
dysautonomia of Gullian Barre syndrome. Fluctuating hypertension 
was found in a patient with porphyria secondary to dysautonomia. 
Persistent hypertension was seen in 6 patients with primary 
hypertension, 1 patient with PAN, 1 patient with Takayasu’s 
arteritis. 1 patient with ESRD and 1 patient with blunt injury 
abdomen. 
 
17. The patient with SLE though had no documented hypertension it 
was postulated that probably she had transient hypertension that 
was undocumented following the reversible nephritis she had.  
 
18. The patient with blunt injury abdomen following RTA had 
persistent hypertension, though a definite cause for hypertension 
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was not deducted - this patient had injury, contusion to the lower 
pole of right kidney. It was postulated probably he had 
renovascular injury as well that would have caused the 
hypertension and Posterior Reversible Encephalopathy Syndrome. 
However his renal artery Doppler study was normal. 
 
19. Amongst the 31 patients on examination 7 patients (22.58%) had 
papillodema. All these patients had documented hypertension, 3 
had PIH, and 4 had accelerated hypertension secondary to primary 
hypertension. 
 
20. Radiological features in these patients were, occipital lobe 
involvement was seen in 24 out of 31 patients i.e.77.41 % of 
patients had occipital lobe involvement, parietal lobe involvement 
was seen in 21 out of 31 patients (67.74 %), both occipital and 
parietal lobe involvement was seen in 16 out of the 31 patients 
(51.61 %). Temporal lobe involvement was seen in 15 out of 31 
(48.38 %). Frontal lobe involvement was seen in 6 out of 31 
patients (19.35 %), other area involvement was seen in 2 out of 31 
patients (6.45%) – 1 patient with postpartum eclampsia had 
bilateral capsuloganglionic vasogenic edema with no diffusion 
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restriction, one another patient with primary hypertension had 
bilateral capsuloganglionic, bilateral corona radiata, bilateral 
centrum semiovale, brainstem and cerebellar vasogenic edema 
without diffusion restriction. 
 
21. In this study the commonest lobe involved was occipital (77.4%) 
followed by parietal (67.74%), followed by temporal (48.38%), 
further followed by frontal (19.35%) and other areas including 
brain stem (6.45%). 
 
 
 
Fig 15: Lobes affected in PRES 
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Fig 16: Lobes involved in PRES 
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1. Symmetrical lesions were found in 21 out of the 31 patients 
(67.74%). 10 patients had asymmetrical lesions (32.25%). 
 
Fig 17: CT Brain showing symmetrical hypodensity in the  
bilateral occipital lobes in a case of PRES 
 
 
Fig 18  
Fig 18 & 19: MRI Br
parieto-occipital hyperintensities in a case of PRES
Fig 20: MRI Brain T2 FLAIR coronal showing subcortical white 
matter hyperintensities in the bilateral frontal lobes
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2. All the patients had vasogenic edema, the h
commonly seen in the subcortical regions of the bilateral parieto
occipital lobes. 
VASOGENIC EDEMA
Fig 21: MRI ADC sequence: showing a hyperintense area in the 
posterior subcortical region of brain.
Fig 22: MRI Brain DWI sequ
corresponding posterior subcortical region suggestive of vasogenic 
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3. Subcortical lesions were found in all the 31 patients. Cortical lesion 
was seen in 14 out of the 31 patients (45.16%). 15 patient
48.38% of the patients had both cortical and subcortical lesions.
 
4. Diffusion restriction was noted in 4 out of 31 patients i.e. 12.90% 
of the patients showed diffusion restriction.
 
 
Fig 21: Diffusion Restriction 
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 Fig 22: DWI Brain 
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showing diffusion bright lesion in the bilateral 
–complication of PRES – Infarct showing 
Diffusion Restriction 
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Fig 23: ADC Brain showing hypointense lesions in the corresponding 
bilateral occipital region-complication of PRES - Infarct. 
Fig 24 & 25: showing diffusion restriction in the bilateral parietal 
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regions 
 
5. Though Posterior Reversible Encephalopathy Syndrome is largely 
reversible, sometimes there can be irreversible complications. In 
this study 28 patients had reversible complications, 2 patients had 
irreversible (visual defects) complications and 1 patient died.
 
 
 
6. Recurrent PRES can occur rarely. One of the patient with ESRD on 
dialysis developed PRES twice
following renal hypertension. 
   
    
 
0
5
10
15
20
25
30
reversible
28
48 
Fig 25: Outcome of PRES 
, at an interval of 6 months,
 
irreversible death
2 1
OUTCOME OF PRES
 
 
 
49 
 
SUMMARY OF THE RESULTS 
 
1. Females are predominantly affected with F: M ratio = 7:1.  
2. The commonest age group affected in this study is between 22 – 39 
years.  
3. Headache is the commonest symptom of Posterior Reversible 
Encephalopathy Syndrome in this study. 
4. Duration of headache ranged from ≤ 1 day up to 14 days, at the time of 
presentation to the hospital. 
5. The commonest aetiology of Posterior Reversible Encephalopathy 
Syndrome is pregnancy induced hypertension. 18 patients (58.06%) out 
of the 31 cases in this study were pregnancy related. All these patients 
were primigravida except one. Amongst the 18 patients 8 had 
antepartum eclampsia, 6 had preeclampsia and 4 had postpartum 
eclampsia. 
6. Hypertension was documented in 21(67.74%) out of the 31 patients. The 
range of hypertension varied from 130/96 to as high as 210/140 mmHg.  
7. With the control of blood pressure symptoms resolved promptly. One of 
the patient with bilateral cortical blindness regained normal vision 
within 4 hours after blood pressure control. 
8. On examination papillodema was seen in 7 patients (22.58%) of the 
patients out of the 31 cases. 
9. The commonest lobes involved were the occipital 77.41% and parietal 
67.74%. 
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10. Vasogenic edema, the prime radiological finding of Posterior Reversible 
Encephalopathy Syndrome was seen in all the patients in this study. 
11. Symmetrical lesion on imaging was seen in 67.74% of the patients.  
12. All had subcortical white matter changes. 48.38% of the patients had 
both subcortical and cortical involvement 
13. Diffusion restriction was seen in 12.9% of the patients. 
14. In most of the cases the symptoms were reversible. However irreversible 
complication (visual defects) was seen in 2 (6%) of the patients. 1 
patient died due to worsening of the primary illness. 
15. Recurrent PRES was seen in 1 out of the 31 (3.22%) of the patients. 
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DISCUSSION 
  Posterior Reversible Encephalopathy Syndrome is common in 
females as most of the cases are pregnancy related. In this study also 
there was a marked female preponderance with 87% of the patients being 
females and only 13% being males.  
Posterior Reversible Encephalopathy Syndrome commonly affects 
young and middle age individuals, the mean age being 39 years to 
47years in various studies (14).  
In this study Posterior Reversible Encephalopathy Syndrome was 
common in the ages 20 – 39 years with the mean of 26.34 years. This 
finding is consistent with the feature that this disease entity is common in 
the young and middle age group (1)(14).  
Also in a case study from India – case series of 20 patients by 
Praveen Kumar et al, with Posterior Reversible Encephalopathy 
Syndrome 60 % of the patients were in the age group 20 – 30 years, a 
finding almost similar to our study.  
Posterior Reversible Encephalopathy Syndrome has been reported 
in patients who are 4 years old up to 90 years old(14). Hinchey reported 
that the youngest patient in their case series was 15 years and the oldest 
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was 62 years. In our case study the youngest was 15 years of age and the 
oldest was 65 years of age. 
In most of the studies worldwide, impaired consciousness was the 
commonest symptom of Posterior Reversible Encephalopathy Syndrome 
(1,2,3,7,19). However in our study headache (87.59%) and seizures 
(64.51%) were the commonest symptoms of Posterior Reversible 
Encephalopathy Syndrome.  
Praveen Kumar et al reported headache (75%) as the most common 
symptom of Posterior Reversible Encephalopathy Syndrome followed by 
seizures, as seen in our study. Abrupt raise in blood pressure of any 
etiology (as encountered in pregnancy related hypertension) is often the 
cause of Posterior Reversible Encephalopathy Syndrome.  
Pregnancy related Posterior Reversible Encephalopathy Syndrome 
was the commonest cause of Posterior Reversible Encephalopathy 
Syndrome in our study followed by primary hypertension. Praveen 
Kumar et al also reported that pregnancy induced hypertension (55%)  as 
the commonest etiology of Posterior Reversible Encephalopathy 
Syndrome followed by primary hypertension. This was consistent with 
Petrovic et al, Lee et al, Casey et al studies that primary hypertension and 
pregnancy induced hypertension are the commonest etiology. Also in 
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Jennifer Fugate et al study Primary Hypertension was the commonest 
cause. However Hinchey et al, Legriel et al, found immunosuppressive 
drugs following transplantation was the commonest cause.  
Hinchey et al, Burnett et al, Bartynski et al documented 
hypertension in 67 – 80 % of the patients; in our study hypertension was 
noted in 67.74% of the patients. 
In the radiological findings, occipital lobe involvement was seen in 
93 %( 1) to 99 %(3, 19) of the patients followed by parietal 87%(1), 99 
%(3), 67%(12) 50%(6). In our study also the commonest lobes affected 
were occipital 77.41% and parietal 67.74% lobes.  
Symmetrical lesions were reported in 100%(7) 69%(6) of the 
patients. In our study the symmetrical pattern was seen in 67.74% of the 
patients.  
Asymmetrical pattern was seen in 32.25% of the patients. 
Subcortical involvement was seen in all the patients. Cortical 
involvement was seen in 13 out of the 31 patients i.e. 41.93% of the 
patients had cortical involvement. Also this means that the same 41.93% 
of the patients had both subcortical and cortical involvement.  
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Vasogenic edema (iso or hypointense in DWI and hyperintense in 
ADC) pathognomonic of Posterior Reversible Encephalopathy Syndrome 
was seen in all cases especially in the posterior subcortical regions.  
Rarely there can be recurrent Posterior Reversible Encephalopathy 
Syndrome. Recurrent Posterior Reversible Encephalopathy Syndrome 
had been reported in 6% of the case(12).In our study one patient (3.22%) 
had recurrent Posterior Reversible Encephalopathy Syndrome. Legriel et 
el reports 15% mortality rate in Posterior Reversible Encephalopathy 
Syndrome. 
Lee et al (14) reported persistent neurological deficit was seen in 
26% of the patients. In our study two of the patients had irreversible 
complications (visual defects) and one patient died of the primary illness. 
The mortality rate in our study was 3.22%. 
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CONCLUSION 
 
* Posterior Reversible Encephalopathy Syndrome is common in 
females, with a female : male ratio of 7 :1. 
 
* The commonest age groups affected are the young and the middle 
aged, 64%of the patients were in this age group.  
 
* Headache (87.09%) is the commonest symptom of Posterior 
Reversible Encephalopathy Syndrome in this study. Seizures 
(64.51%) was the second most common symptom in this study. 
One half of the patients had the other symptoms of PRES - 
impaired consciousness, visual symptoms and vomiting.  
 
* Papillodema is seen in nearly 1/3rd of the patients.  
 
* Not all patients have documented hypertension. Hypertension was 
documented in 64.75% of the patients in this study, the rest, 
32.26% of the patients had no hypertension signifying that the 
abrupt rise of blood pressure from the baseline, is more important 
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than the absolute value of blood pressure in causing Posterior 
Reversible Encephalopathy Syndrome.  
 
* The commonest cause is Pregnancy related Posterior Reversible 
Encephalopathy Syndrome, with almost all the pregnant patients 
being primigravida. 
 
* There is varied aetiology for Posterior Reversible Encephalopathy 
Syndrome, ranging from the commoner  pregnancy related 
Posterior Reversible Encephalopathy Syndrome to the rare causes 
like porphyria, Posterior Reversible Encephalopathy Syndrome 
following blunt injury abdomen, following OPC poisoning etc, as 
seen in this study. Hence a high index of suspicion and a thorough 
knowledge of conditions that could predispose to Posterior 
Reversible Encephalopathy Syndrome is essential for the early 
diagnosis.  
 
* The commonest radiological pattern is subcortical, symmetrical 
vasogenic edema in the occipoparietal regions. However cortical 
involvement was seen in nearly 50% of the patients. Asymmetrical 
involvement was seen in nearly 1/3rd of the patients. 
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* Recurrent PRES is observed in a small percentage (3.22%) of 
patients. 
* Prompt control of blood pressure prevents irreversible 
complications.  
* A high index of clinical suspicion in appropriate settings along 
with radiological correlation, will help in early recognition and 
prompt management of PRES, which will aid in preventing grave 
complications. 
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PROFORMA 
NAME    : 
AGE     : 
GENDER    : 
OCCUPATION   : 
ADDRESS    : 
PHONE NO   : 
CLINICAL SPECTRUM : 
 Headache 
 Visual Impairment 
 Seizures 
 Altered Sensorium 
 Focal neurological deficit 
 Fundi 
 Blood Pressure  
 Other system examination  
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ETIOLOGY    :  
 Eclampsia - Antepartum  
                        -Postpartum 
 Pre – eclampsia 
 Accelerated hypertension 
 Renal  
     -  Renal Parenchymal Disease  
     -  Reno Vascular Disease 
 Vasculitis  
 Connective  Tissue Disorders 
 Dysautonomia-Gullian Barre Syndrome 
 Drugs and Toxins 
 Others  
RADIOLOGICAL SPECTRUM :  
   Areas Involved  
 Posterior white matter lesion  
 Anterior white matter lesion 
 Posterior and  Anterior white matter lesion 
 Subcortical lesion 
 Cortical lesion 
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 Subcortical and Cortical lesion 
 Vasogenic edema  
 Vasogenic edema+areas of diffusion restriction, if any. 
 Occipital 
 parietal 
 temporal 
 frontal 
 Cerebellum 
 Brainstem 
BLOOD INVESTIGATIONS: 
 Complete Blood Count 
 ESR 
 CRP 
 Urea 
 Creatinine 
 Sugar 
 ANA 
 RA  factor 
 ANCA 
 Elisa for retrovirus 
 HBsAg 
 Anti-HCV antibody 
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 URINE ANALYSIS 
 Urine Routine 
 Urine Spot Protein: Creatinine ratio 
 24- hr urinary protein 
EEG 
CXR- PA view 
ECG 
USG whole abdomen 
Renal Artery Doppler 
Carotid Doppler 
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O P T F Others
1 Kudiya Devi Y Y N N N Y N N Y Y Y Y N AP eclampsia
2 Jamuna N Y N N N Y N N Y N N N N Pre-eclampsia
3 Janaki Y N N N N Y N N Y N N N N AP eclampsia
4 Gomathy Y N N N N Y N N Y N N N N Pre-eclampsia
5 Radha Y Y Y N N Y (R) parietal infarct 0 Y N N N N Accelerated HTN
6 Amulu Y Y N N N Y (R) parietal small infarct N N Y N Y N AP eclampsia
7 Sangeetha Y (R) Y Y N N Y N N Y N N N Y PIGN with PRES
8 Kala N (R) Y Y B/L Capsulo ganglionic Y N N Y N Y Y N PP-eclampsia
9 Kanika Y Y N N N Y N N Y N N Y N Takayasu's arteritas with PRES
10 Prema Y N N N N Y N N Y N N Y N PP-eclampsia
11 Jaya Y N N N N Y N N Y N N Y N PP-eclampsia
12 Therasa Y Y Y N N Y B/L occipital infarct N Y Y Y Y N Accelerated HTN
13 Kavitha N N N N N N N N Y N Y N N Pre-eclampsia
14 Angali Y Y N N N N N N Y N Y N N PP-eclampsia
15 Ranjith Y (R) Y Y N Y
B/L occipital 
pole small 
infarct
N Y Y N N Y Accelerated HTN, Blunt injury abdomen (R) Kidney contussion
16 Suresh Y Y Y Y N Y N N Y Y Y Y N PAN with PRES
17 Kousalya N Y Y N N Y N N Y Y Y Y N PP eclampsia
18 Loganayaki N Y N N N Y N N Y Y Y Y N Acclerated HTN
19 Malar N Y N N N Y N N Y N N Y N Pre-eclampsia
20 Kumari Y Y Y Y N Y N N Y Y Y Y N SLE with PRES
21 Chandra Y Y Y Y N Y N N Y Y Y Y N Acclerated HTN
22 Sankari Y (R) occipital Y Y N N Y N N Y Y Y N Y AP eclampsia
23 Durga Y Y Y N N Y N N Y Y Y Y N AP eclampsia
24 Ambika Y N Y N N Y N N Y N N Y N Pre-eclampsia
25 Vidhya Y Y N N N Y N N Y N N Y N OPC poisoning, toxic neuropathy with acute dysautonomia
26 Bhavani Y (R) occipital Y N N N Y N N Y N N N Y AP eclampsia
27 Devi Y N N N N Y N N Y N N Y N Pre-eclampsia
28 Dinesh Y Y Y Y N Y N N Y Y Y Y N porphyria with SIADH, SHT with PRES
29 Valli Y Y Y N N Y N N Y Y Y Y N AP eclampsia
30 Arulanathan Y (R) occipital N B/L temporal N
B/L Capsulo 
ganglionic, B/L 
coronoradiata, 
centrum 
semiovale
Y N N Y N N Y N Malignant HT with PRES
31 Akila N Y n N N Y N N Y Y Y Y N ESRD on hemodialysis, recurrent PRES
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